Dearborn Partners Has Boosted Its Abbott Labs (ABT) Stake, Earnest Partners Raised Banco Bradesco (BBD) Position By $20.56 Million

June 26, 2017 - By Clifton Ray

Dearborn Partners Llc increased Abbott Labs (ABT) stake by 33.99% reported in 2016Q4 SEC filing. Dearborn Partners Llc acquired 15,930 shares as Abbott Labs (ABT)’s stock declined 3.42%. The Dearborn Partners Llc holds 62,793 shares with $2.41 million value, up from 46,863 last quarter. Abbott Labs now has $84.84B valuation. The stock decreased 0.39% or $0.19 on June 23, reaching $49.08. About shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since June 26, 2016 and is uptrending. It has underperformed by 0.80% the S&P500.

Earnest Partners Llc increased Banco Bradesco (BBD) stake by 22.49% reported in 2016Q4 SEC filing. Earnest Partners Llc acquired 2.57M shares as Banco Bradesco (BBD)’s stock declined 11.39%. The Earnest Partners Llc holds 14.00M shares with $121.91 million value, up from 11.43 million last quarter. Banco Bradesco now has $47.80 billion valuation. The stock decreased 0.75% or $0.06 on June 23, reaching $7.94. About shares traded. Banco Bradesco SA (ADR) (NYSE:BBD) has risen 43.32% since June 26, 2016 and is uptrending. It has outperformed by 26.62% the S&P500.

Among 18 analysts covering Abbott Laboratories (NYSE:ABT), 10 have Buy rating, 0 Sell and 8 Hold. Therefore 56% are positive. Abbott Laboratories had 52 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Monday, April 17 by Cowen & Co. The firm has “Overweight” rating by Barclays Capital given on Wednesday, October 7. Goldman Sachs downgraded it to “Neutral” rating and $90 target in Friday, November 13 report. Jefferies upgraded Abbott Laboratories (NYSE:ABT) rating on Monday, December 7. Jefferies has “Buy” rating and $55 target. The stock has “Equal-Weight” rating by Morgan Stanley on Monday, January 4. Argus Research upgraded the stock to “Buy” rating in Friday, February 5 report. The firm earned “Buy” rating on Thursday, August 4 by Jefferies. The firm has “Buy” rating by Jefferies given on Thursday, July 14. The firm has “Outperform” rating by RBC Capital Markets given on Friday, October 9. The stock has “Neutral” rating by Piper Jaffray on Thursday, April 28.

Investors sentiment increased to 1.01 in 2016 Q4. Its up 0.05, from 0.96 in 2016Q3. It is positive, as 83 investors sold ABT shares while 496 reduced holdings. 103 funds opened positions while 481 raised stakes. 1.06 billion shares or 1.63% more from 1.04 billion shares in 2016Q3 were reported. Metropolitan Life Communication New York has invested 0.21% in Abbott Laboratories (NYSE:ABT). Beacon holds 18,106 shares or 0.11% of its portfolio. 266 are owned by Cornerstone Incorporated. Sg Americas Securities Limited Liability owns 1.28M shares or 0.41% of their US portfolio. Madison Inc owns 13,973 shares. Concert Wealth Management Inc invested in 22,263 shares. 1832 Asset LP stated it has 840 shares or 0% of all its holdings. Bedrijfstakpensioenfonds Voor De Media Pno holds 0.12% of its portfolio in Abbott Laboratories (NYSE:ABT) for 23,500 shares. Kcg Hldgs holds 0.18% of its portfolio in Abbott Laboratories (NYSE:ABT) for 185,612 shares. Farmers Merchants invested in 96,506 shares. Mcrae Capital Mngmt stated it has 0.18% in Abbott Laboratories (NYSE:ABT). Tower Bridge Advsrs reported 43,982 shares or 0% of all its holdings. The California-based Utd Capital Advisers Limited Liability Company has invested 0.19% in Abbott Laboratories (NYSE:ABT). Nelson Roberts Inv Advsr Ltd Llc holds 2,520 shares. Spinnaker Trust has invested 0.14% in Abbott Laboratories (NYSE:ABT).

Dearborn Partners Llc decreased Nestle Sa Adr (NSRGY) stake by 11,265 shares to 176,622 valued at $12.67M in 2016Q4. It also reduced Praxair Inc (NYSE:PX) stake by 3,047 shares and now owns 63,544 shares. Procter & Gamble Co (NYSE:PG) was reduced too.

Since January 31, 2017, it had 1 buy, and 20 selling transactions for $8.46 million activity. 319 shares were sold by NATH DEEPAK S., worth $14,349 on Friday, February 17. $1.46M worth of Abbott Laboratories (NYSE:ABT) shares were sold by Mason Heather L. The insider BIRD ROGER sold $72,069. Contreras Jaime had sold 13,155 shares worth $592,157. Watkin Jared sold 552 shares worth $26,482. 857 Abbott Laboratories (NYSE:ABT) shares with value of $38,569 were sold by ALLEN HUBERT L. $4.20M worth of Abbott Laboratories (NYSE:ABT) shares were sold by CAPEK JOHN M.

Among 6 analysts covering Banco Bradesco SA (NYSE:BBD), 2 have Buy rating, 1 Sell and 3 Hold. Therefore 33% are positive. Banco Bradesco SA had 9 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was upgraded by Bank of America to “Buy” on Monday, March 14. The rating was downgraded by Deutsche Bank on Tuesday, March 22 to “Hold”. Goldman Sachs maintained the shares of BBD in report on Monday, May 2 with “Neutral” rating. The stock of Banco Bradesco SA (ADR) (NYSE:BBD) has “Neutral” rating given on Wednesday, September 21 by Goldman Sachs. Citigroup downgraded the shares of BBD in report on Friday, April 8 to “Sell” rating. The stock of Banco Bradesco SA (ADR) (NYSE:BBD) has “Buy” rating given on Monday, October 12 by Deutsche Bank. On Tuesday, March 15 the stock rating was initiated by Scotia Capital with “Underperform”. On Wednesday, April 12 the stock rating was upgraded by Scotia Capital to “Sector Perform”.

Earnest Partners Llc decreased Union Pac Corp (NYSE:UNP) stake by 64,964 shares to 217,504 valued at $22.55M in 2016Q4. It also reduced Chubb Ltd stake by 27,871 shares and now owns 59,862 shares. Raymond James (NYSE:RJF) was reduced too.